TuHURA Biosciences
HURA
24 hedge funds and large institutions have $374K invested in TuHURA Biosciences in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
20% more funds holding
Funds holding: 20 → 24 (+4)
0% less ownership
Funds ownership: 0% → 0% (-0%)
61% less capital invested
Capital invested by funds: $972K → $374K (-$598K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$87.6K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$62K |
| 3 |
VF
Virtu Financial
New York
|
+$30.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8.31K |
| 5 |
HF
HRT Financial
New York
|
+$7.03K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$124K |
| 2 |
Renaissance Technologies
New York
|
-$81.8K |
| 3 |
Millennium Management
New York
|
-$6.08K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$639 |
| 5 |
TAM
Tucker Asset Management
Littleton,
Colorado
|
-$278 |
HURA Hedge Fund Activity: Q3 2022 in Review
24 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q3 2022, worth a combined $374K — down 61% from $972K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new HURA positions and 2 closed out — a net gain of 4 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was Nantahala Capital Management, adding an estimated $87.6K. The largest seller was Vanguard Group, cutting an estimated $124K.
- 24 institutional investors held TuHURA Biosciences (HURA) as of Q3 2022, up from 20 in Q2 2022.
- Funds reported $374K of TuHURA Biosciences stock for Q3 2022, down 61% quarter-over-quarter.
- 6 funds opened new TuHURA Biosciences positions in Q3 2022 and 2 closed out, a net change of +4 holders.
- The largest TuHURA Biosciences buyer in Q3 2022 was Nantahala Capital Management, an estimated $87.6K added.
- The largest TuHURA Biosciences seller in Q3 2022 was Vanguard Group, an estimated $124K sold.
Based on aggregated 13F filings for Q3 2022.